NCT01662999View on ClinicalTrials.gov

Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Saxagliptin

DRUG

Dapagliflozin

Trial Locations (1)

68154

Icon Clinical Pharmacology, Omaha

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY